In view of the pro-thrombotic role of platelet NOXs both in vitro and in vivo (Figure 2), the upregulation of NOX1 in DM patients contributes significantly to platelet hyperresponsiveness. This evidence concerns the gene NOX1 and diabetes mellitus.